Indication:
Drug Name- Raxibacumab
Active Ingredient - Raxibacumab
To treat inhalational anthrax, a form of infectious disease caused by breathing
in spores of the the bacterium Bacillus anthracis
Indication-
To treat inhalational anthrax, a form of infectious disease caused by breathing
in spores of the the bacterium Bacillus anthracis
Approved by FDA on 14-12--2012 (Ref- FDA approved List- 2012)
Dosages/ Overdosage Etc:
Indication-
To treat inhalational anthrax, a form of infectious disease caused by breathing
in spores of the the bacterium Bacillus anthracis